Astonishing as it might sound, a major, complex and important health care bill is making its way through Congress with broad bipartisan support. The legislation was on track to be completed this month but has hit a snag over differences…
The Galen Institute focuses primarily on health and tax policy research. We encourage you to view the latest developments on this page, or learn more about a specific topic from the left menu.
Prescription Drugs
The prescription drug crisis: Et tu, Washington? February 27, 2012 Commentary
The tragic death of Whitney Houston has once again shined the spotlight on the abuse of prescription drugs and the doctors who prescribe them. Legislators, experts and pundits are blaming physicians for liberally prescribing narcotics, but an honest debate must…
Bureaucratic Delay Costs Lives February 3, 2012 Commentary
One of the countless concerns with growing government control over the health sector is additional bureaucratic delay in getting new treatments to patients. We’re seeing more and more evidence of these hurdles. And we have another example involving a new…
Big Brother Is Watching Your Doctor January 30, 2012 Commentary
One of the biggest fears the American people have about the new health overhaul law is that government will control decisions involving their health care, usurping the doctor-patient relationship. They have reason to be afraid. A report is in which…
Lipitor And The Future Of Pharmaceutical Innovation December 12, 2011 Commentary
Today, nearly 80 percent of all prescriptions in the U.S. are filled with generics, and the percentage will rise when more than 10 major drugs go off patent in 2012. Late last month, the most popular drug in history, Lipitor,…